Chromatin-wide profiling of DYRK1A reveals a role as a gene-specific RNA polymerase II CTD kinase

Molecular Cell

Volumn 57, Issue 3, 2015, Pages 506-520

  Vona, Chiara D ^a,b,c   Bezdan, Daniela ^a,b   Islam, Abul B M M K ^b,d   Salichs, Eulàlia ^a,b,c   López Bigas, Nuria ^b,e   Ossowski, Stephan ^a,b   Luna, Susana D L ^a,b,c,e  

^a CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^d UNIVERSITY OF DHAKA   (Bangladesh)

^e INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DYRK1A PROTEIN; HETEROCHROMATIN PROTEIN 1; PROTEIN; RNA POLYMERASE II; UNCLASSIFIED DRUG; CARBOXY-TERMINAL DOMAIN KINASE; DYRK KINASE; MESSENGER RNA; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; SERINE;

ARTICLE; BINDING AFFINITY; BIOGENESIS; CARBOXY TERMINAL SEQUENCE; CELL CYCLE PROGRESSION; CHROMATIN; CONSENSUS SEQUENCE; GENE ACTIVITY; GENE EXPRESSION PROFILING; GENE TARGETING; GENETIC ASSOCIATION; GENETIC MANIPULATION; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; NONHUMAN; PROMOTER REGION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; RNA PROCESSING; RNA SPLICING; TRANSCRIPTION INITIATION; TRANSLATION INITIATION; BINDING SITE; CELL NUCLEUS; CHEMISTRY; GENETIC TRANSCRIPTION; GENETICS; HELA CELL LINE; INVERTED REPEAT; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; TUMOR CELL LINE;

MAMMALIA;

BINDING SITES; CELL LINE, TUMOR; CELL NUCLEUS; HELA CELLS; HUMANS; INVERTED REPEAT SEQUENCES; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; RNA POLYMERASE II; RNA, MESSENGER; SERINE; TRANSCRIPTION, GENETIC;

EID: 84924902637     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2014.12.026     Document Type: Article

References (49)

1. Alvarez M., Estivill X., de la Luna S. DYRK1A accumulates in splicing speckles through a novel targeting signal and induces speckle disassembly. J.Cell Sci. 2003, 116:3099-3107.
2. Aranda S., Alvarez M., Turró S., Laguna A., de la Luna S. Sprouty2-mediated inhibition of fibroblast growth factor signaling is modulated by the protein kinase DYRK1A. Mol. Cell. Biol. 2008, 28:5899-5911.
3. Aranda S., Laguna A., de la Luna S. DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles. FASEB J. 2011, 25:449-462.
4. Arron J.R., Winslow M.M., Polleri A., Chang C.P., Wu H., Gao X., Neilson J.R., Chen L., Heit J.J., Kim S.K., et al. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 2006, 441:595-600.
5. Baek S.H. When signaling kinases meet histones and histone modifiers in the nucleus. Mol. Cell 2011, 42:274-284.
6. Barski A., Cuddapah S., Cui K., Roh T.Y., Schones D.E., Wang Z., Wei G., Chepelev I., Zhao K. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129:823-837.
7. Blazek D., Kohoutek J., Bartholomeeusen K., Johansen E., Hulinkova P., Luo Z., Cimermancic P., Ule J., Peterlin B.M. The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes. Genes Dev. 2011, 25:2158-2172.
8. Chapman R.D., Heidemann M., Albert T.K., Mailhammer R., Flatley A., Meisterernst M., Kremmer E., Eick D. Transcribing RNA polymerase II is phosphorylated at CTD residue serine-7. Science 2007, 318:1780-1782.
9. Chen J.Y., Lin J.R., Tsai F.C., Meyer T. Dosage of Dyrk1a shifts cells within a p21-cyclin D1 signaling map to control the decision to enter the cell cycle. Mol. Cell 2013, 52:87-100.
10. Courcet J.B., Faivre L., Malzac P., Masurel-Paulet A., Lopez E., Callier P., Lambert L., Lemesle M., Thevenon J., Gigot N., et al. The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy. J.Med. Genet. 2012, 49:731-736.
11. Czudnochowski N., Bösken C.A., Geyer M. Serine-7 but not serine-5 phosphorylation primes RNA polymerase II CTD for P-TEFb recognition. Nat. Commun. 2012, 3:842.
12. Fernandez-Martinez J., Vela E.M., Tora-Ponsioen M., Ocaña O.H., Nieto M.A., Galceran J. Attenuation of Notch signalling by the Down-syndrome-associated kinase DYRK1A. J.Cell Sci. 2009, 122:1574-1583.
13. Fotaki V., Dierssen M., Alcántara S., Martínez S., Martí E., Casas C., Visa J., Soriano E., Estivill X., Arbonés M.L. Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice. Mol. Cell. Biol. 2002, 22:6636-6647.
14. Guimera J., Casas C., Estivill X., Pritchard M. Human minibrain homologue (MNBH/DYRK1): characterization, alternative splicing, differential tissue expression, and overexpression in Down syndrome. Genomics 1999, 57:407-418.
15. Gwack Y., Sharma S., Nardone J., Tanasa B., Iuga A., Srikanth S., Okamura H., Bolton D., Feske S., Hogan P.G., Rao A. A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT. Nature 2006, 441:646-650.
16. Himpel S., Tegge W., Frank R., Leder S., Joost H.G., Becker W. Specificity determinants of substrate recognition by the protein kinase DYRK1A. J.Biol. Chem. 2000, 275:2431-2438.
17. Hong J.Y., Park J.I., Lee M., Muñoz W.A., Miller R.K., Ji H., Gu D., Ezan J., Sokol S.Y., McCrea P.D. Down's-syndrome-related kinase Dyrk1A modulates the p120-catenin-Kaiso trajectory of the Wnt signaling pathway. J.Cell Sci. 2012, 125:561-569.
18. Hsin J.P., Manley J.L. The RNA polymerase II CTD coordinates transcription and RNA processing. Genes Dev. 2012, 26:2119-2137.
19. Hu S., Xie Z., Onishi A., Yu X., Jiang L., Lin J., Rho H.S., Woodard C., Wang H., Jeong J.S., et al. Profiling the human protein-DNA interactome reveals ERK2 as a transcriptional repressor of interferon signaling. Cell 2009, 139:610-622.
20. Jang S.M., Azebi S., Soubigou G., Muchardt C. DYRK1A phoshorylates histone H3 to differentially regulate the binding of HP1 isoforms and antagonize HP1-mediated transcriptional repression. EMBO Rep. 2014, 15:686-694.
21. Kaczmarski W., Barua M., Mazur-Kolecka B., Frackowiak J., Dowjat W., Mehta P., Bolton D., Hwang Y.W., Rabe A., Albertini G., Wegiel J. Intracellular distribution of differentially phosphorylated dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A). J.Neurosci. Res. 2014, 92:162-173.
22. Laguna A., Aranda S., Barallobre M.J., Barhoum R., Fernández E., Fotaki V., Delabar J.M., de la Luna S., de la Villa P., Arbonés M.L. The protein kinase DYRK1A regulates caspase-9-mediated apoptosis during retina development. Dev. Cell 2008, 15:841-853.
23. Larochelle S., Amat R., Glover-Cutter K., Sansó M., Zhang C., Allen J.J., Shokat K.M., Bentley D.L., Fisher R.P. Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II. Nat. Struct. Mol. Biol. 2012, 19:1108-1115.
24. Lee Y., Ha J., Kim H.J., Kim Y.S., Chang E.J., Song W.J., Kim H.H. Negative feedback Inhibition of NFATc1 by DYRK1A regulates bone homeostasis. J.Biol. Chem. 2009, 284:33343-33351.
25. Litovchick L., Florens L.A., Swanson S.K., Washburn M.P., DeCaprio J.A. DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly. Genes Dev. 2011, 25:801-813.
26. Lloyd A.C. The regulation of cell size. Cell 2013, 154:1194-1205.
27. Lockstone H.E., Harris L.W., Swatton J.E., Wayland M.T., Holland A.J., Bahn S. Gene expression profiling in the adult Down syndrome brain. Genomics 2007, 90:647-660.
28. Malinge S., Bliss-Moreau M., Kirsammer G., Diebold L., Chlon T., Gurbuxani S., Crispino J.D. Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome. J.Clin. Invest. 2012, 122:948-962.
29. Mao J., Maye P., Kogerman P., Tejedor F.J., Toftgard R., Xie W., Wu G., Wu D. Regulation of Gli1 transcriptional activity in the nucleus by Dyrk1. J.Biol. Chem. 2002, 277:35156-35161.
30. Martí E., Altafaj X., Dierssen M., de la Luna S., Fotaki V., Alvarez M., Pérez-Riba M., Ferrer I., Estivill X. Dyrk1A expression pattern supports specific roles of this kinase in the adult central nervous system. Brain Res. 2003, 964:250-263.
31. Møller R.S., Kübart S., Hoeltzenbein M., Heye B., Vogel I., Hansen C.P., Menzel C., Ullmann R., Tommerup N., Ropers H.H., et al. Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly. Am. J. Hum. Genet. 2008, 82:1165-1170.
32. Ortiz-Abalia J., Sahún I., Altafaj X., Andreu N., Estivill X., Dierssen M., Fillat C. Targeting Dyrk1A with AAVshRNA attenuates motor alterations in TgDyrk1A, a mouse model of Down syndrome. Am. J. Hum. Genet. 2008, 83:479-488.
33. Pique-Regi R., Degner J.F., Pai A.A., Gaffney D.J., Gilad Y., Pritchard J.K. Accurate inference of transcription factor binding from DNA sequence and chromatin accessibility data. Genome Res. 2011, 21:447-455.
34. Platts A.E., Dix D.J., Chemes H.E., Thompson K.E., Goodrich R., Rockett J.C., Rawe V.Y., Quintana S., Diamond M.P., Strader L.F., Krawetz S.A. Success and failure in human spermatogenesis as revealed by teratozoospermic RNAs. Hum. Mol. Genet. 2007, 16:763-773.
35. Pozo N., Zahonero C., Fernández P., Liñares J.M., Ayuso A., Hagiwara M., Pérez A., Ricoy J.R., Hernández-Laín A., Sepúlveda J.M., Sánchez-Gómez P. Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth. J.Clin. Invest. 2013, 123:2475-2487.
36. Qian W., Liang H., Shi J., Jin N., Grundke-Iqbal I., Iqbal K., Gong C.X., Liu F. Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A. Nucleic Acids Res. 2011, 39:6161-6171.
37. Rachdi L., Kariyawasam D., Guez F., Aïello V., Arbonés M.L., Janel N., Delabar J.M., Polak M., Scharfmann R. Dyrk1a haploinsufficiency induces diabetes in mice through decreased pancreatic beta cell mass. Diabetologia 2014, 57:960-969.
38. Raghav S.K., Waszak S.M., Krier I., Gubelmann C., Isakova A., Mikkelsen T.S., Deplancke B. Integrative genomics identifies the corepressor SMRT as a gatekeeper of adipogenesis through the transcription factors C/EBPβ and KAISO. Mol. Cell 2012, 46:335-350.
39. Roepcke S., Zhi D., Vingron M., Arndt P.F. Identification of highly specific localized sequence motifs in human ribosomal protein gene promoters. Gene 2006, 365:48-56.
40. Soppa U., Schumacher J., Florencio Ortiz V., Pasqualon T., Tejedor F.J., Becker W. The Down syndrome-related protein kinase DYRK1A phosphorylates p27(Kip1) and Cyclin D1 and induces cell cycle exit and neuronal differentiation. Cell Cycle 2014, 13:2084-2100.
41. Suganuma T., Workman J.L. Chromatin and signaling. Curr. Opin. Cell Biol. 2013, 25:322-326.
42. Tee W.W., Shen S.S., Oksuz O., Narendra V., Reinberg D. Erk1/2 activity promotes chromatin features and RNAPII phosphorylation at developmental promoters in mouse ESCs. Cell 2014, 156:678-690.
43. Tejedor F., Zhu X.R., Kaltenbach E., Ackermann A., Baumann A., Canal I., Heisenberg M., Fischbach K.F., Pongs O. minibrain: a new protein kinase family involved in postembryonic neurogenesis in Drosophila. Neuron 1995, 14:287-301.
44. van Bon B.W., Hoischen A., Hehir-Kwa J., de Brouwer A.P., Ruivenkamp C., Gijsbers A.C., Marcelis C.L., de Leeuw N., Veltman J.A., Brunner H.G., de Vries B.B. Intragenic deletion in DYRK1A leads to mental retardation and primary microcephaly. Clin. Genet. 2011, 79:296-299.
45. Wang J., Zhuang J., Iyer S., Lin X., Whitfield T.W., Greven M.C., Pierce B.G., Dong X., Kundaje A., Cheng Y., et al. Sequence features and chromatin structure around the genomic regions bound by 119 human transcription factors. Genome Res. 2012, 22:1798-1812.
46. Wong K.H., Jin Y., Struhl K. TFIIH phosphorylation of the Pol II CTD stimulates mediator dissociation from the preinitiation complex and promoter escape. Mol. Cell 2014, 54:601-612.
47. Wyrwicz L.S., Gaj P., Hoffmann M., Rychlewski L., Ostrowski J. A common cis-element in promoters of protein synthesis and cell cycle genes. Acta Biochim. Pol. 2007, 54:89-98.
48. Xie X., Lu J., Kulbokas E.J., Golub T.R., Mootha V., Lindblad-Toh K., Lander E.S., Kellis M. Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. Nature 2005, 434:338-345.
49. Yamashita D., Sano Y., Adachi Y., Okamoto Y., Osada H., Takahashi T., Yamaguchi T., Osumi T., Hirose F. hDREF regulates cell proliferation and expression of ribosomal protein genes. Mol. Cell. Biol. 2007, 27:2003-2013.